ISRG Intuitive Surgical Inc

$ISRG big spot here vs prior range lows. Above that and hold and were lookin at puch back to range highs. About to get a monthly MacD cross if can hold. 430/440

$ISRG Bears cooked when it breaks the 429 S/R pivot. That is bullish weekly engulfing candle. I'm up almost 20% already.

$ISRG For years now, the bears have been sayimg that competition is a potential problem for ISRG. Thus far, they have been completely wrong! ISRG has stayed in the forefront of robotic surgery and it seems will stay there! Each quarter is a beat and the conservative company seems to be its own worst enemy by being so conservative on future earnings. Perhaps a dividend will make it more attractive to investors!

$ISRG Just bought a few shares of this, this morning. It was the only one that popped up while I was screening some stocks. Glad I bought in. Wasn't expecting a move on the same day. 👍🏿

$ISRG <<-- would shape the future of surgery: a surgeon-controlled robotic platform that combines precise instruments, real-time data, and AI-assisted insights. Imagine an operating room where surgical data, heart rate, blood pressure, and anesthesia information work together to help the care team make better decisions. That’s the long-term vision

$ISRG | Technical Setup 📉🤖 • Structure: $ISRG has mounted a sharp relief bounce off macro demand at $328.00–$352.50, reclaiming $371.98 support and coiling right below mid-range volume resistance at $400.47. A decisive breakout over $400.47 opens the door for a retest of structural pivot levels at $429.00 and $440.10. • Catalyst: Strong procedure volume expansion driven by da Vinci 5 adoption and accelerated international system placements. 🎯 Key Levels: 🐂 Bull Trigger: $393.23 / $400.47 🚀 Targets: $429.00 / $440.10 / $455.10 🛡️ Support: $371.98 / $352.50 ⚠️ Risk: $352.50 / $328.00 #ISRG #stocks #trading #medtech #hovdid

$ISRG Ready for that 400 psychological war. feels like we just gonna zig zag back and forth around 382 to 405 till it gaps up to 410 one morning. Lets gooooo 💪

$ISRG Reports Q3 after the close Tuesday. Zacks consensus is 2.61 dollars in EPS on 2.88 billion dollars in revenue, up about 9% and 15% from a year ago. The bar underneath is procedures and placements. Analysts expect 902,959 procedures vs 797,000 a year ago, and 475 system placements vs 427, with the da Vinci installed base at 12,080 vs 10,763. It has beaten in each of the last four quarters, average surprise 16.53%.

$ISRG $PFE | BULLISH SETUP 🐂 ⭐ Setup Quality Grade: B+ 📌 Grade Justification: • Profitability: Top 15th Percentile (72.8% gross margin, 27.9% operating margin, $2.80–$3.00 FY26 EPS guidance, robust 6.16% dividend yield). • Options Flow: Heavy Bullish Sweeps ($129.3K sweep on Oct $28C at ask, $60.4K sweep on Oct $28.5C, $38.6K sweep on Nov $28.5C). • Technical Setup: A- Grade Cleanliness (Textbook 1W macro trendline breakout holding $27.00–$28.00 volume shelf support with RSI curling up off base). • Wall St Target: +10%–28%+ Upside ($30.00–$36.00 consensus price targets). 🏢 Profile: Global biopharmaceutical titan ($156B+ market cap) delivering non-COVID oncology and pipeline growth alongside a high 6.16% dividend yield. 🔎 Options Flow: Oct 16 $28C (0.3% ITM) ($129.3K sweep at ask). 🎯 Levels: • Bulls: Hold $27.00 & claim $29.25 ➡️ Targets: $31.00 / $33.50 / $36.00+. • Bears: Break under $25.50 support. #hovdid

$ISRG From peak to trough, the stock fell ~45% as revenue, net income and free cash flows continue to climb. Stock price follows earnings.

$ISRG something is brewing here! Consistently trying to break through 415. Once that breaks Might fly

$ISRG The 50MA was a key resistance during this sell off, broken. Resistance trendline from ATHs, broken. Short-term resistance at 405.50, broken. Outlook and technical update soon. I'm up double digits % already. Buy moats, especially monopolies, when they temporarily fall.